Free Trial
→ Trump Orders 'National Digital Asset Stockpile' (From Crypto 101 Media) (Ad) Buy BDRX Stock  Free BDRX Stock Alerts

Biodexa Pharmaceuticals (BDRX) SEC Filings & 10K Form

Biodexa Pharmaceuticals logo
$1.46 -0.19 (-11.52%)
Closing price 04:00 PM Eastern
Extended Trading
$1.42 -0.04 (-2.74%)
As of 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Biodexa Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
04/11/2025
7:41 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/11/2025
7:43 AM		Biodexa Pharmaceuticals (Filer)
Form 20-F
Registration statement / Annual report / Transition report  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/06/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/24/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/18/2025
3:30 PM		Biodexa Pharmaceuticals (Subject)
C/M CAPITAL PARTNERS, LP (Filed by)
Form SCHEDULE 13G
02/13/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
02/10/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/27/2025
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
01/28/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/22/2025
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/21/2025
5:27 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:30 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:21 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:24 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/21/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/17/2025
3:49 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
01/17/2025
3:21 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/08/2025
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
01/08/2025
5:18 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
12/27/2024
4:15 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/20/2024
10:56 AM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G/A
11/05/2024
5:09 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:15 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:06 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/05/2024
5:03 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
11/01/2024
4:18 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
Now I look stupid. Real stupid... (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/16/2024
8:12 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
10/15/2024
4:14 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
10/04/2024
7:30 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/27/2024
3:41 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/26/2024
7:42 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/20/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/19/2024
3:30 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/16/2024
7:40 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
09/06/2024
6:54 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/30/2024
3:38 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/19/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
08/20/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
08/12/2024
3:36 PM		Biodexa Pharmaceuticals (Filer)
Form F-1
Registration statement for securities of certain foreign private issuers  
08/08/2024
3:24 PM		Biodexa Pharmaceuticals (Subject)
Iroquois Capital Management, LLC (Filed by)
Form SC 13G
08/01/2024
2:37 PM		Biodexa Pharmaceuticals (Filer)
Form D
Notice of Exempt Offering of Securities 
07/23/2024
2:09 PM		Biodexa Pharmaceuticals (Subject)
Brio Capital Master Fund Ltd. (Filed by)
Form SC 13G
07/23/2024
7:55 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
4:13 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/22/2024
8:34 AM		Biodexa Pharmaceuticals (Filer)
Form 424B5
07/19/2024
12:00 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K/A
07/19/2024
8:03 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/16/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
Elon Set to Shock the World by May 1st ? (Ad)

Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believes will be Elon’s greatest invention ever… Yes, even bigger than Tesla or SpaceX.

Click here now because after May 1st, it could be too late.
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/11/2024
4:27 PM		Biodexa Pharmaceuticals (Filer)
Form 424B3
07/05/2024
4:24 PM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
07/02/2024
7:44 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2024
7:46 AM		Biodexa Pharmaceuticals (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/16/2024
11:15 PM		Biodexa Pharmaceuticals (Filer)
Form EFFECT
06/17/2024
5:00 AM		Biodexa Pharmaceuticals (Filer)
Form 424B3
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:BDRX) was last updated on 4/15/2025 by MarketBeat.com Staff
From Our Partners
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...
Colonial Metals | Sponsored
Get Your Bank Account “Fed Invasion” Ready with THESE 4 Simple Steps
Starting as soon as a few months from now, the United States government will make a sweeping change to bank ac...
Weiss Ratings | Sponsored
The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
Paradigm Press | Sponsored
Elon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to Mars
Elon Musk just confirmed Tesla’s robot will go to Mars. But on Earth, it may trigger a trillion-dollar tech sh...
InvestorPlace | Sponsored
America’s Retirement Accounts Are at Risk—Here’s Why
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
Collect $7k per month from Tesla’s SECRET dividend
Tesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...
Investors Alley | Sponsored
Trump to redistribute trillions of dollars
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
My friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...
Crypto Swap Profits | Sponsored